5AXI image
Deposition Date 2015-07-29
Release Date 2016-03-02
Last Version Date 2024-11-13
Entry Detail
PDB ID:
5AXI
Title:
Crystal structure of Cbl-b TKB domain in complex with Cblin
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.26
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:E3 ubiquitin-protein ligase CBL-B
Gene (Uniprot):Cblb
Chain IDs:A, B, C
Chain Length:307
Number of Molecules:3
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Cblin
Chain IDs:D (auth: E)
Chain Length:5
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Structural analysis of the TKB domain of ubiquitin ligase Cbl-b complexed with its small inhibitory peptide, Cblin
Arch.Biochem.Biophys. 594 1 7 (2016)
PMID: 26874193 DOI: 10.1016/j.abb.2016.02.014

Abstact

Cbl-b is a RING-type ubiquitin ligase. Previously, we showed that Cbl-b-mediated ubiquitination and proteosomal degradation of IRS-1 contribute to muscle atrophy caused by unloading stress. The phospho-pentapeptide DGpYMP (Cblin) mimics Tyr612-phosphorylated IRS-1 and inhibits the Cbl-b-mediated ubiquitination and degradation of IRS-1 in vitro and in vivo. In this study, we confirmed the direct interaction between Cblin and the TKB domain of Cbl-b using NMR. Moreover, we showed that the shortened tripeptide GpYM also binds to the TKB domain. To elucidate the inhibitory mechanism of Cblin, we solved the crystal structure of the TKB-Cblin complex at a resolution of 2.5 Å. The pY in Cblin inserts into a positively charged pocket in the TKB domain via hydrogen-bond networks and hydrophobic interactions. Within this complex, the Cblin structure closely resembles the TKB-bound form of another substrate-derived phosphopeptide, Zap-70-derived phosphopeptide. These peptides lack the conserved intrapeptidyl hydrogen bond between pY and a conserved residue involved in TKB-domain binding. Instead of the conserved interaction, these peptides specifically interact with the TKB domain. Based on this binding mode of Cblin to the TKB domain, we can design drugs against unloading-mediated muscle atrophy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures